Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Agile Therapeutics stock price on Wednesday which ended trading at $0.370
(Updated on Mar 27, 2024)

Sell candidate since Dec 22, 2023 Loss -81.03% PDF

The Agile Therapeutics stock price gained 10.78% on the last trading day (Wednesday, 27th Mar 2024), rising from $0.334 to $0.370. During the last trading day the stock fluctuated 28.81% from a day low at $0.325 to a day high of $0.418. The price has fallen in 6 of the last 10 days and is down by -47.59% for this period. Volume fell on the last day by -1 million shares and in total, 461 thousand shares were bought and sold for approximately $170.72 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.310 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -69.41% during the next 3 months and, with a 90% probability hold a price between $0.0947 and $0.201 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 10.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agile Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.503 and $0.83. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Agile Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.334. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0935 between high and low, or 28.81%. For the last week the stock has had daily average volatility of 26.70%.

Agile Therapeutics is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGRX) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Agile Therapeutics to open at $0.371, and during the day (based on 14 day Average True Range), to move between $0.258 and $0.482, which gives a possible trading interval of +/-$0.112 (+/-30.25%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 60.50% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.334, some $0.0360 (9.73%) from the current price of $0.370, our system finds the risk reward attractive.

Is Agile Therapeutics stock A Buy?

Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.206 Strong Sell Candidate Unchanged

Predicted Opening Price for Agile Therapeutics of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.371 ( 0.225%) $0.370

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.464 25.50 %
R2 0.429 15.84 %
R1 0.407 9.88 %
Current price: 0.370
Support S1 0.335 -9.43 %
S2 0.313 -15.39 %
S3 0.277 -25.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.370
Support S1 0.334 -9.73%
S2 0 .
S3 0 .

FAQ

What is the symbol for Agile Therapeutics Stock and on which exchange is it traded?
The symbol for Agile Therapeutics is AGRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agile Therapeutics Stock?
Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Agile Therapeutics Stock?
Agile Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agile Therapeutics Stock.

What's the current price of Agile Therapeutics Stock?
As of the end of day on the 2024-03-27, the price of an Agile Therapeutics (AGRX) share was $0.370.

What is the 52-week high and low for Agile Therapeutics Stock?
The 52-week high for Agile Therapeutics Stock is $9.13 and the 52-week low is $0.200.

What is the market capitalization of Agile Therapeutics Stock?
As of the 2024-03-27, the market capitalization of Agile Therapeutics is 989.862K.

When is the next earnings date for Agile Therapeutics?
The upcoming earnings date for Agile Therapeutics is Mar 28, 2024.
Click to get the best stock tips daily for free!

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT